Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Invesco Biotechnology & Genome ETF (NY:PBE)

97.90 -0.82 (-0.83%)

Streaming Delayed Price Updated: 12:15 PM EDT, Sep 4, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,281
Open	98.00
Bid (Size)	97.79 (600)
Ask (Size)	97.98 (600)
Prev. Close	98.72
Today's Range	97.64 - 98.00
52wk Range	67.69 - 98.82
Shares Outstanding	34,500
Dividend Yield	3.31%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? ↗

August 21, 2026

IHE delivered 53.2% returns over one year with lower volatility and a 0.37% expense ratio, while PBE's quantitative biotech strategy carries higher risk.

Via The Motley Fool

IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? ↗

August 21, 2026

PBE concentrates on 31 companies and offers a higher dividend yield, while IBBQ spreads risk across 251 holdings at a fraction of the cost.

Via The Motley Fool

Performance

YTD	+18.9%	+18.9%
1 Month	+7.0%	+7.0%
3 Month	+16.3%	+16.3%
6 Month	+24.3%	+24.3%
1 Year	+38.7%	+38.7%

More News

VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? ↗

August 12, 2026

Via The Motley Fool

MannKind Stock Soared 8% Today: Why A Surge In Afrezza Inhaled Insulin Sales Matters ↗

November 05, 2025

Via Stocktwits

Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion ↗

October 29, 2025

Via Stocktwits

Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease ↗

September 23, 2025

Via Stocktwits

XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist? ↗

August 01, 2026

Via The Motley Fool

VHT vs. PBE: Which Health Care ETF Is the Better Buy? ↗

July 30, 2026

Via The Motley Fool

Why Did MNKD Stock Jump Over 7% In Pre-Market Today? ↗

January 26, 2026

Via Stocktwits

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗

September 29, 2025

Via Benzinga

3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential ↗

February 19, 2024

Via InvestorPlace

Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention ↗

April 13, 2023

Via Benzinga

Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules ↗

April 13, 2023

Via Benzinga

New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗

April 12, 2023

Via Benzinga

Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗

April 11, 2023

Via Benzinga

FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits ↗

April 06, 2023

Via Benzinga

US Judge Weighs Nationwide Ban On Abortion Pills ↗

March 16, 2023

Via Benzinga

FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' ↗

March 01, 2023

Via Benzinga

7 Best Biotech Stocks to Buy in July 2022 ↗

July 08, 2022

Via InvestorPlace

Biotech ETFs That Outperformed Last Week ↗

December 20, 2021

Via Talk Markets

A Comprehensive Guide To Genomic ETFs ↗

July 11, 2021

Via Talk Markets

5 Top ETFs With Exposure To Biogen ↗

June 07, 2021

Via Talk Markets

5 Top ETFs With Exposure To Biogen ↗

June 07, 2021

Via Benzinga

3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More ↗

May 30, 2021

Via Talk Markets

Frequently Asked Questions

Is Invesco Biotechnology & Genome ETF publicly traded?

Yes, Invesco Biotechnology & Genome ETF is publicly traded.

What exchange does Invesco Biotechnology & Genome ETF trade on?

Invesco Biotechnology & Genome ETF trades on the New York Stock Exchange

What is the ticker symbol for Invesco Biotechnology & Genome ETF?

The ticker symbol for Invesco Biotechnology & Genome ETF is PBE on the New York Stock Exchange

What is the current price of Invesco Biotechnology & Genome ETF?

The current price of Invesco Biotechnology & Genome ETF is 97.90

When was Invesco Biotechnology & Genome ETF last traded?

The last trade of Invesco Biotechnology & Genome ETF was at 09/04/26 12:15 PM ET

What is the market capitalization of Invesco Biotechnology & Genome ETF?

The market capitalization of Invesco Biotechnology & Genome ETF is 3.38M

How many shares of Invesco Biotechnology & Genome ETF are outstanding?

Invesco Biotechnology & Genome ETF has 3M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.